Issued Patents All Time
Showing 1–21 of 21 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11952601 | Recombinant botulinum toxin with increased duration of effect | Fred Hofmann, Marcel JURK, Manuela López De La Paz, Daniel Scheps | 2024-04-09 |
| 11155802 | Recombinant botulinum neurotoxins with increased duration of effect | Fred Hofmann, Marcel JURK, Manuela López De La Paz, Daniel Scheps | 2021-10-26 |
| 11078472 | Recombinant clostridial neurotoxins with increased duration of effect | Fred Hofmann, Marcel JURK, Manuela López De La Paz, Daniel Scheps | 2021-08-03 |
| 10603353 | Recombinant clostridial neurotoxins with increased duration of effect | Fred Hofmann, Michael Schmidt, Manuela López De La Paz, Daniel Scheps | 2020-03-31 |
| 9975929 | Recombinant clostridial neurotoxins with increased duration of effect | Fred Hofmann, Michael Schmidt | 2018-05-22 |
| 9827298 | Neurotoxins exhibiting shortened biological activity | Fred Hofmann | 2017-11-28 |
| 9809809 | Neurotoxins exhibiting shortened biological activity | Michael Schmidt, Fred Hofmann, Gerhard Groer | 2017-11-07 |
| 9511114 | Neurotoxins exhibiting shortened biological activity | Fred Hofmann | 2016-12-06 |
| 9193771 | Neurotoxins exhibiting shortened biological activity | Fred Hofmann | 2015-11-24 |
| 9186396 | PEGylated mutated Clostridium botulinum toxin | Volker Specht | 2015-11-17 |
| 8912140 | PEGylated mutated clostridium botulinum toxin | Volker Specht | 2014-12-16 |
| 8895713 | Clostridial neurotoxins with altered persistency | — | 2014-11-25 |
| 8748151 | Clostridial neurotoxins with altered persistency | — | 2014-06-10 |
| 8586329 | Neurotoxins exhibiting shortened biological activity | Fred Hofmann | 2013-11-19 |
| 8398998 | Therapeutic composition comprising a botulinum neurotoxin | Hans Bigalke | 2013-03-19 |
| 8298550 | PEGylated mutated Clostridium botulinum toxin | Volker Specht | 2012-10-30 |
| 8003601 | Pegylated mutated clostridium botulinum toxin | Volker Specht | 2011-08-23 |
| 7964199 | Therapeutic composition comprising a botulinum neurotoxin | Hans Bigalke | 2011-06-21 |
| 7829525 | Formulation for a protein pharmaceutical without added human serum albumin (HSA) | — | 2010-11-09 |
| 6822076 | Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof | Hans Bigalke | 2004-11-23 |
| 6573241 | Therapeutic agent for the suppression of snoring noises | Hans Bigalke | 2003-06-03 |